0 of 10 questions completed
You have already completed the assessment before. Hence you can not start it again.
Assessment is loading…
You must sign in or sign up to start the assessment.
You must first complete the following:
0 of 10 questions answered correctly
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Most of the current CAR T-cell trials for myeloma target which protein?
BCMA CAR T-cells lessons from initial studies in refractory patients include all of the following except:
Some potential ways to optimize CAR T-cell treatment in myeloma patients include(s):
In the initial registration studies of Diffuse Large B-Cell Lymphoma patients treated with CAR T-cells:
An institution developing a CAR T-cell treatment program should include Medical Informatics in the planning to develop:
CAR T-cell-Related Encephalopathy Syndrome (CRES)
The current cost of the approved CAR T-cell products is:
Value based care is impacted by:
Current FY19 Medicare CAR T-cell inpatient payment is based on the diagnosis
Some patients are treated with CAR T –cell therapy as an outpatient.